Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa M Ebert

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Journal for Immunotherapy of Cancer|May 16, 2024
Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancersTessa Gargett, Nga T H Truong, Bryan Gardam, et al.
Molecular Oncology|July 10, 2021
Desmoglein-2 expression is an independent predictor of poor prognosis patients with multiple myelomaLisa M Ebert, Kate Vandyke, M Zahied Johan, et al.
Frontiers in Immunology|June 30, 2023
Plasma glycoproteomic biomarkers identify metastatic melanoma patients with reduced clinical benefit from immune checkpoint inhibitor therapyChad Pickering, Paul Aiyetan, Gege Xu, et al.
Cancer Research|January 30, 2009
A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine designLisa M Ebert, Yu Chih Liu, Craig S Clements, et al.
Oncotarget|June 25, 2016
Desmoglein 2 promotes vasculogenic mimicry in melanoma and is associated with poor clinical outcomeLih Yin Tan, Chris Mintoff, M Zahied Johan, et al.
Science Advances|October 25, 2023
Human cerebrospinal fluid affects chemoradiotherapy sensitivities in tumor cells from patients with glioblastomaBrett W Stringer, Manam Inushi De Silva, Zarina Greenberg, et al.
Iscience|March 20, 2026
Tumors located in the brain impair the frequency and phenotype of dendritic cells in blood and tumorBryan Gardam, Tessa Gargett, Eunwoo Nam, et al.
Journal for Immunotherapy of Cancer|September 27, 2022
GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastomaTessa Gargett, Lisa M Ebert, Nga T H Truong, et al.
BMC Biomedical Engineering|April 1, 2021
3D-printed microplate inserts for long term high-resolution imaging of live brain organoidsMariana Oksdath Mansilla, Camilo Salazar-Hernandez, Sally L Perrin, et al.
Angiogenesis|June 25, 2016
A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesisLisa M Ebert, Lih Y Tan, M Zahied Johan, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Journal for Immunotherapy of Cancer|May 16, 2024
Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancersTessa Gargett, Nga T H Truong, Bryan Gardam, et al.
Molecular Oncology|July 10, 2021
Desmoglein-2 expression is an independent predictor of poor prognosis patients with multiple myelomaLisa M Ebert, Kate Vandyke, M Zahied Johan, et al.
Frontiers in Immunology|June 30, 2023
Plasma glycoproteomic biomarkers identify metastatic melanoma patients with reduced clinical benefit from immune checkpoint inhibitor therapyChad Pickering, Paul Aiyetan, Gege Xu, et al.
Cancer Research|January 30, 2009
A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine designLisa M Ebert, Yu Chih Liu, Craig S Clements, et al.
Oncotarget|June 25, 2016
Desmoglein 2 promotes vasculogenic mimicry in melanoma and is associated with poor clinical outcomeLih Yin Tan, Chris Mintoff, M Zahied Johan, et al.
Science Advances|October 25, 2023
Human cerebrospinal fluid affects chemoradiotherapy sensitivities in tumor cells from patients with glioblastomaBrett W Stringer, Manam Inushi De Silva, Zarina Greenberg, et al.
Iscience|March 20, 2026
Tumors located in the brain impair the frequency and phenotype of dendritic cells in blood and tumorBryan Gardam, Tessa Gargett, Eunwoo Nam, et al.
Journal for Immunotherapy of Cancer|September 27, 2022
GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastomaTessa Gargett, Lisa M Ebert, Nga T H Truong, et al.
BMC Biomedical Engineering|April 1, 2021
3D-printed microplate inserts for long term high-resolution imaging of live brain organoidsMariana Oksdath Mansilla, Camilo Salazar-Hernandez, Sally L Perrin, et al.
Angiogenesis|June 25, 2016
A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesisLisa M Ebert, Lih Y Tan, M Zahied Johan, et al.
Pageof 6